Recently, Neural Galaxy partners with Beijing Foundation for Disabled Persons (BFDP) to launch a Clinical Trial project for Autism families. According to statistics, there’re around 10M ASD patients in China, more than 2M under 12 years old, with a lack of effective solutions of treatment globally.
This commonweal project is intended for exploring a new therapy to help Autism patients improving their core abilities to better integrate into society. Neural Galaxy’s POINT Therapy is developed for providing neuromodulation at “Personalized Brain Functional Network” level, under pBFS.
For more information, please check the link (in Chinese) https://www.neuralgalaxy.cn/news?id=298835270504093 , which also provides application form by scanning the QR Code. (This project opens to ASD families from outside Beijing too, as long as the self-supporting travel and patient’s caregiver is available.)